Myriad Genetics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $213,100 | $195,900 | $210,600 | $213,300 |
Gross Profit | 151,800 | 134,200 | 150,900 | 149,800 |
EBITDA | -315,000 | -14,200 | -23,600 | -2,200 |
EBIT | -329,100 | -28,600 | -38,400 | -17,800 |
Net Income | -330,500 | -100 | -42,500 | -22,100 |
Net Change In Cash | 213,100 | 195,900 | 210,600 | 213,300 |
Free Cash Flow | -20,500 | -24,600 | 700 | -5,600 |
Cash | 74,400 | 91,800 | 102,400 | 99,900 |
Basic Shares | 92,500 | 91,400 | 91,100 | 90,900 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $837,600 | $753,200 | $678,400 | $690,600 |
Gross Profit | 585,400 | 517,000 | 476,400 | 493,000 |
EBITDA | -59,500 | -186,100 | -67,800 | 14,100 |
EBIT | -120,700 | -248,000 | -123,700 | -48,700 |
Net Income | -127,300 | -263,300 | -112,000 | -27,200 |
Net Change In Cash | 837,600 | 753,200 | 678,400 | 690,600 |
Free Cash Flow | -38,400 | -184,200 | -151,600 | 600 |
Cash | 102,400 | 132,100 | 56,900 | 258,400 |
Basic Shares | 90,600 | 82,800 | 80,600 | 78,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.05 |
2025-03-31 | -$0.03 |
2024-12-31 | $0.03 |
